Kissei Pharmaceutical Co., Ltd.
KSPHF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | $88 | $76 | $67 | $65 |
| % Growth | 16.9% | 12% | 3.2% | – |
| Cost of Goods Sold | $44 | $38 | $0 | $0 |
| Gross Profit | $44 | $37 | $0 | $0 |
| % Margin | 49.9% | 49.4% | 0.3% | 0.4% |
| R&D Expenses | $0 | $0 | $10 | $10 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $38 | $0 | $20 | $20 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $33 | $3 | $2 |
| Operating Expenses | $38 | $33 | $34 | $33 |
| Operating Income | $6 | $4 | -$1 | -$1 |
| % Margin | 6.5% | 5.3% | -1.7% | -2.1% |
| Other Income/Exp. Net | $10 | $10 | $15 | $18 |
| Pre-Tax Income | $16 | $14 | $14 | $17 |
| Tax Expense | $4 | $3 | $3 | $3 |
| Net Income | $12 | $11 | $11 | $13 |
| % Margin | 13.5% | 14.8% | 15.6% | 19.8% |
| EPS | 274.21 | 246.58 | 228.31 | 280.2 |
| % Growth | 11.2% | 8% | -18.5% | – |
| EPS Diluted | 274.21 | 246.58 | 228.31 | 280.2 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $5 | $4 | $4 | $4 |
| EBITDA | $20 | $19 | $3 | $2 |
| % Margin | 22.9% | 24.8% | 4.4% | 3.6% |